Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Buchfelder

Showing results (191-200 of 212) with videos related to

Pageof 22
Sort By:
Endocrine-Related Cancer|October 20, 2011
RSUME is implicated in HIF-1-induced VEGF-A production in pituitary tumour cellsB Shan, J Gerez, M Haedo, et al.
Oncogene|May 10, 2016
MIF-CD74 signaling impedes microglial M1 polarization and facilitates brain tumorigenesisA Ghoochani, M A Schwarz, E Yakubov, et al.
European Journal of Endocrinology|November 9, 2011
DG3173 (somatoprim), a unique somatostatin receptor subtypes 2-, 4- and 5-selective analogue, effectively reduces GH secretion in human GH-secreting pituitary adenomas even in Octreotide non-responsive tumoursU Plöckinger, U Hoffmann, M Geese, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|April 1, 1993
[Medulloblastomas--the results after postoperative radiotherapy with and without adjuvant chemotherapy]G G Grabenbauer, C Löhnert, J Erhardt, et al.
Pituitary|November 18, 2000
Prolactin-producing pituitary adenoma and carcinoma with neuronal components--a metaplastic lesionB W Scheithauer, E Horvath, K Kovacs, et al.
European Journal of Endocrinology|March 30, 2012
Tumour recurrence and enlargement in patients with craniopharyngioma with and without GH replacement therapy during more than 10 years of follow-upD S Olsson, M Buchfelder, K Wiendieck, et al.
Epilepsia|February 24, 2001
Magnetic resonance spectroscopy and histopathological findings in temporal lobe epilepsyH Stefan, M Feichtinger, E Pauli, et al.
Pituitary|July 26, 2012
Variation of the baseline characteristics and treatment parameters over time: an analysis of 15 years of growth hormone replacement in adults in the German KIMS databaseI Kreitschmann-Andermahr, S Siegel, F Francis, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|July 18, 2000
Supratentorial low-grade glioma: results and prognostic factors following postoperative radiotherapyG G Grabenbauer, C M Roedel, W Paulus, et al.
Endocrine-Related Cancer|September 4, 2009
Curcumin acts as anti-tumorigenic and hormone-suppressive agent in murine and human pituitary tumour cells in vitro and in vivoC Schaaf, B Shan, M Buchfelder, et al.
Pageof 22

Showing results (191-200 of 212) with videos related to

Sort By:
Pageof 22
Endocrine-Related Cancer|October 20, 2011
RSUME is implicated in HIF-1-induced VEGF-A production in pituitary tumour cellsB Shan, J Gerez, M Haedo, et al.
Oncogene|May 10, 2016
MIF-CD74 signaling impedes microglial M1 polarization and facilitates brain tumorigenesisA Ghoochani, M A Schwarz, E Yakubov, et al.
European Journal of Endocrinology|November 9, 2011
DG3173 (somatoprim), a unique somatostatin receptor subtypes 2-, 4- and 5-selective analogue, effectively reduces GH secretion in human GH-secreting pituitary adenomas even in Octreotide non-responsive tumoursU Plöckinger, U Hoffmann, M Geese, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|April 1, 1993
[Medulloblastomas--the results after postoperative radiotherapy with and without adjuvant chemotherapy]G G Grabenbauer, C Löhnert, J Erhardt, et al.
Pituitary|November 18, 2000
Prolactin-producing pituitary adenoma and carcinoma with neuronal components--a metaplastic lesionB W Scheithauer, E Horvath, K Kovacs, et al.
European Journal of Endocrinology|March 30, 2012
Tumour recurrence and enlargement in patients with craniopharyngioma with and without GH replacement therapy during more than 10 years of follow-upD S Olsson, M Buchfelder, K Wiendieck, et al.
Epilepsia|February 24, 2001
Magnetic resonance spectroscopy and histopathological findings in temporal lobe epilepsyH Stefan, M Feichtinger, E Pauli, et al.
Pituitary|July 26, 2012
Variation of the baseline characteristics and treatment parameters over time: an analysis of 15 years of growth hormone replacement in adults in the German KIMS databaseI Kreitschmann-Andermahr, S Siegel, F Francis, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|July 18, 2000
Supratentorial low-grade glioma: results and prognostic factors following postoperative radiotherapyG G Grabenbauer, C M Roedel, W Paulus, et al.
Endocrine-Related Cancer|September 4, 2009
Curcumin acts as anti-tumorigenic and hormone-suppressive agent in murine and human pituitary tumour cells in vitro and in vivoC Schaaf, B Shan, M Buchfelder, et al.
Pageof 22